These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34116983)

  • 1. Letter in response to "Thromboembolic events in atrial fibrillation: Different level of risk and pattern between peripheral artery disease and coronary artery disease" by Lin et al.
    Ryu R
    Arch Cardiovasc Dis; 2021; 114(6-7):518-519. PubMed ID: 34116983
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboembolic events in atrial fibrillation: Different level of risk and pattern between peripheral artery disease and coronary artery disease.
    Lin YS; Wu VC; Chen YL; Liu CH; Chen HC; Lee WC; Yang TY; Aboyans V; Chen MC
    Arch Cardiovasc Dis; 2021 Mar; 114(3):176-186. PubMed ID: 33518472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease.
    Coleman CI; Baker WL; Meinecke AK; Eriksson D; Martinez BK; Bunz TJ; Alberts MJ
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):159-166. PubMed ID: 31549153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
    Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS
    Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Place of non-vitamin K antagonist oral anticoagulants in anticoagulant-antiplatelet combinations in peripheral artery disease.
    Stephan D; Cordeanu EM; Mirea C; Faller A; Lejay A; Gaertner S
    Arch Cardiovasc Dis; 2016 Nov; 109(11):634-640. PubMed ID: 27692662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
    Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
    Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of peripheral artery disease in proven coronary patients in Abidjan Heart Institute of Côte d'Ivoire].
    Niamkey JT; Yao H; Matanga J; Ekou A; Kouamé I; N'Guetta R
    Ann Cardiol Angeiol (Paris); 2021 Feb; 70(1):13-17. PubMed ID: 32950211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.
    Xanthopoulou I; Dragona VM; Davlouros P; Tsioufis C; Iliodromitis E; Alexopoulos D;
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):191-196. PubMed ID: 29679301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation and vascular disease: Coronary artery disease and/or peripheral artery disease?
    Essa H; Lip GYH
    Arch Cardiovasc Dis; 2021 Mar; 114(3):173-175. PubMed ID: 33712401
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation.
    Pastori D; Pignatelli P; Sciacqua A; Perticone M; Violi F; Lip GYH
    Int J Cardiol; 2018 Mar; 255():69-73. PubMed ID: 29290420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ankle-brachial index screening for peripheral artery disease in high cardiovascular risk patients. Prospective observational study of 370 asymptomatic patients at high cardiovascular risk].
    Rada C; Oummou S; Merzouk F; Amarir B; Boussabnia G; Bougrini H; Benzaroual D; Elkarimi S; Elhattaoui M
    J Mal Vasc; 2016 Dec; 41(6):353-357. PubMed ID: 27865565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Outcome: A Population-Based Nationwide Study From the SWEDEHEART Registry.
    Taha A; Nielsen SJ; Bergfeldt L; Ahlsson A; Friberg L; Björck S; Franzén S; Jeppsson A
    J Am Heart Assoc; 2021 Jan; 10(1):e017966. PubMed ID: 33251914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
    Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry.
    Boivin-Proulx LA; Deneault-Marchand A; Matteau A; Mansour S; Gobeil F; Camm JA; Fox KAA; Potter BJ
    Clin Cardiol; 2020 Mar; 43(3):216-221. PubMed ID: 31850592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI.
    Hohnloser SH; Steg PG; Oldgren J; Nickenig G; Kiss RG; Ongen Z; Navarro Estrada JL; Oude Ophuis T; Lip GYH; Nordaby M; Kleine E; Ten Berg JM; Bhatt DL; Cannon CP;
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1553-1561. PubMed ID: 31439336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atheromatous extra-coronary injury in patients with coronary disease: Result of a cross-sectional centre study carried out in the east of Algeria].
    Merghit R; Ait Athmane M; Lakehal A
    Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):201-206. PubMed ID: 30857643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study.
    Lamberts M; Lip GY; Ruwald MH; Hansen ML; Özcan C; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH
    J Am Coll Cardiol; 2014 Jun; 63(24):2689-98. PubMed ID: 24794118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
    Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.